摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,5-dimethoxyphenylamino)-7-((R)-1-hydroxymethyl-2-methylpropylamino)-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile | 824398-56-3

中文名称
——
中文别名
——
英文名称
2-(3,5-dimethoxyphenylamino)-7-((R)-1-hydroxymethyl-2-methylpropylamino)-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile
英文别名
2-(3,5-dimethoxyanilino)-7-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile
2-(3,5-dimethoxyphenylamino)-7-((R)-1-hydroxymethyl-2-methylpropylamino)-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile化学式
CAS
824398-56-3
化学式
C26H28N6O3
mdl
——
分子量
472.547
InChiKey
NEPZGQVKOLOXQH-QHCPKHFHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    35
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    117
  • 氢给体数:
    3
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    2-(3,5-dimethoxyphenylamino)-7-((R)-1-hydroxymethyl-2-methylpropylamino)-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrilesodium hydroxide双氧水 作用下, 以 乙醇二甲基亚砜 为溶剂, 反应 3.0h, 以100%的产率得到2-(3,5-dimethoxyanilino)-7-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-5-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
    参考文献:
    名称:
    Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade
    摘要:
    To improve the in vitro potency of the c-Src inhibitor 1a and to address its hERG liability, a structure-activity study was carried Out, focusing on two regions of the lead compound. The blockade of the delayed cardiac current rectifier K+ (I-Kr) channel was overcome by replacing the ethylenediamino group with an amino alcohol group at the 7-position. In addition, modifying the substituents at the 5-position and the side chain groups on the amino alcohols at the 7-position enhanced the intracellular c-Src inhibitory activity and increased central nervous system (CNS) penetration. In the present study, 6l exhibited significant in vivo efficacy in a middle cerebral artery (MCA) occlusion model in rats. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.10.068
  • 作为产物:
    描述:
    2-(3,5-dimethoxyphenylamino)-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrileD-缬氨醇三乙胺 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 24.0h, 以39%的产率得到2-(3,5-dimethoxyphenylamino)-7-((R)-1-hydroxymethyl-2-methylpropylamino)-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile
    参考文献:
    名称:
    Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade
    摘要:
    To improve the in vitro potency of the c-Src inhibitor 1a and to address its hERG liability, a structure-activity study was carried Out, focusing on two regions of the lead compound. The blockade of the delayed cardiac current rectifier K+ (I-Kr) channel was overcome by replacing the ethylenediamino group with an amino alcohol group at the 7-position. In addition, modifying the substituents at the 5-position and the side chain groups on the amino alcohols at the 7-position enhanced the intracellular c-Src inhibitory activity and increased central nervous system (CNS) penetration. In the present study, 6l exhibited significant in vivo efficacy in a middle cerebral artery (MCA) occlusion model in rats. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.10.068
点击查看最新优质反应信息